A robust meta-classification strategy for cancer detection from MS data

Proteomics. 2006 Jan;6(2):592-604. doi: 10.1002/pmic.200500192.

Abstract

We propose a novel method for phenotype identification involving a stringent noise analysis and filtering procedure followed by combining the results of several machine learning tools to produce a robust predictor. We illustrate our method on SELDI-TOF MS prostate cancer data (http://home.ccr.cancer.gov/ncifdaproteomics/ppatterns.asp). Our method identified 11 proteomic biomarkers and gave significantly improved predictions over previous analyses with these data. We were able to distinguish cancer from non-cancer cases with a sensitivity of 90.31% and a specificity of 98.81%. The proposed method can be generalized to multi-phenotype prediction and other types of data (e.g., microarray data).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Case-Control Studies
  • Decision Support Techniques*
  • Diagnosis, Differential
  • Humans
  • Male
  • Prognosis
  • Prostate / metabolism
  • Prostatic Hyperplasia / diagnosis*
  • Prostatic Neoplasms / classification*
  • Prostatic Neoplasms / diagnosis*
  • Proteomics
  • Reference Standards
  • Sensitivity and Specificity
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / methods*

Substances

  • Biomarkers, Tumor